Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
D000186:Actinium / Q000008:administration & dosage / Q000627:therapeutic use*; D000512:Alpha Particles; D000818:Animals; D001729:Bismuth; D006801:Humans; D008081:Liposomes; D008854:Microscopy, Electron; D009362:Neoplasm Metastasis / Q000532:radiotherapy; D011868:Radioisotopes
D008081:Liposomes; D011868:Radioisotopes; D000186:Actinium; D001729:Bismuth